
Maxion Therapeutics
Developer of a novel platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines mini-proteins found in venom and other sources called ...
Valuation
$110.6M
Latest known
Share Price
N/A
Total Raised
$105.1M
Last Round
N/A